Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,576 | -$4,973 | -$3,687 | -$7,875 |
| Dep. & Amort. | $460 | $541 | $760 | $717 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,751 | $339 | -$236 | $961 |
| Other Non-Cash | $3,454 | $1,490 | $0 | $0 |
| Operating Cash Flow | -$911 | -$2,585 | -$2,365 | -$3,396 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$13 | -$41 | -$37 |
| Net Acquisitions | $0 | $0 | $0 | -$1 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $50 | -$3 | $0 | $203 |
| Investing Cash Flow | $49 | -$15 | -$41 | $165 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $911 | $2,689 | $2,162 | $2,038 |
| Stock Issued | $0 | $0 | $200 | $1,178 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$36 | $0 |
| Financing Cash Flow | $911 | $2,689 | $2,326 | $3,216 |
| Forex Effect | -$84 | -$58 | $71 | -$17 |
| Net Chg. in Cash | -$36 | $31 | -$9 | -$32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $9 | $18 | $50 |
| End Cash | $4 | $40 | $9 | $18 |
| Free Cash Flow | -$912 | -$2,598 | -$2,406 | -$3,433 |